Novo Nordisk sees solid Q1 results, major GLP-1 growth potential, and limited downside despite guidance cut and rising risks.

Teradyne leverages a duopoly in automated test systems, benefiting from strong chipmaker ties. Click here to read why TER ...

Palantir's software is experiencing growth in both the commercial and government sectors. AI adoption in Europe could ...

Key Points Exelixis' most important product should continue driving strong financial results through the end of the ...

According to Anuj Gupta, Director, Ya Wealth Research & Advisory, Reliance Industries share price is expected to have gap-up ...

Key Points Broadcom stock has accumulated gains of more than 2,000% in the past 10 years.Strong demand from tech hyperscalers ...

Taiwan Semiconductor just reported blockbuster results, confirming that the AI revolution is alive and well. Nvidia has ...

QuantumScape could be a good speculative stock to own for the next decade if you expect it to successfully establish an early ...

Anthem Biosciences shares are expected to make strong listing gains on the back of bumper subscription and strong GMP trends.

Most people can't do much about the amount of money they're saving. Most people can, however, get more out of what they're ...

The frosty relations between the U.S. and China adversely affected Nvidia. The new export restrictions meant the company ...

Bonds rated in the CCC range have gained 0.75% this month through Thursday, outpacing all other ratings tiers, including ...